BigHat Biosciences

San Mateo, CA · Founded 2019 · Privately Held (backing)

Developer of an experimental antibody platform designed to empower biological antibodies and other therapeutic proteins. BigHat Biosciences is based in San Mateo, CA and was founded in 2019. It was valued at $332 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $148 million across 3 recorded rounds; the latest was a $124 million later-stage round in Jun 2022.

PMV mark · valuation
$332.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$148.3M
Last round
Later Stage VC
Jun 2022
What is BigHat Biosciences worth?
$332.0MPrivateMarketView mark · Oct 2026

Valued at $332.0M at its later-stage round, Apr 2025. Nothing has traded since.

Free account
More of BigHat Biosciences with a free account
  • ·The complete investor list: 25 names
  • ·Watch BigHat Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

BigHat Biosciences funding history

3 rounds
DateRoundRaisedPost-money
Jun 2022Later Stage VC$124.1M▮
Jan 2021Early Stage VC$18.8M▮
Oct 2019Early Stage VC$5.3M▮
Unlock post-money valuations

Membership and data by Private Market View

BigHat Biosciences valuation

BigHat Biosciences was valued at $332 million at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has BigHat Biosciences raised?

BigHat Biosciences has raised $148 million across 3 recorded rounds since 2019. The largest was a $5.3 million early-stage round in Oct 2019; the most recent was a $124 million later-stage round in Jun 2022.

BigHat Biosciences has filed 4 Form Ds with the SEC since 2019, most recently in Apr 2025 ($124 million sold to 40 investors).

How BigHat Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For BigHat Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about BigHat Biosciences

What is BigHat Biosciences worth?
BigHat Biosciences is valued at $332.0M as of Oct 2026. Valued at $332.0M at its later-stage round, Apr 2025. Nothing has traded since.
How much has BigHat Biosciences raised?
BigHat Biosciences has raised $148.3M in total funding across 3 recorded rounds.
When did BigHat Biosciences last raise?
BigHat Biosciences last raised in Jun 2022 (Later Stage VC), raising $124.1M.